The Pharmacy Times® human immunodeficiency virus (HIV) resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
What can we help you find?
The discovery is the first time a new subtype of HIV-1 has been identified since 2000.
The US Food and Drug Administration (FDA) has authorized marketing of the Sentosa SQ HIV Genotyping Assay, a test that detects HIV-1 drug resistance mutations using next-generation sequencing technology.
Researchers at the National Institute of Health (NIH) and the Massachusetts General Hospital in Boston (MGH) found that tesamorelin reduces liver fat and prevents liver fibrosis in people living with HIV.
New study provides evidence that the use of antiretroviral therapy alters the formation or stabilization of HIV latent reservoirs.
The findings of the retrospective cohort study were presented in a poster at IDWeek 2019.
Understanding which molecules HIV needs in order to leave a cell and multiply is a crucial prerequisite for investigating how the spread can be prevented.
The funding is awarded to health departments representing 57 geographic areas to expand treatment and prevention efforts for HIV/AIDS.
Community Pharmacy Consultant Bruce Kneeland talks with independent pharmacy owner Teresa Dickinson, RPh, discuss compounding at Melrose Pharmacy in Phoenix, Arizona.
Doravirine (Pifeltro, Merck) and doravirine/lamivudine/tenofovir/disoproxil fumarate (Delstrigo) were initially approved for the treatment of HIV in adults with no prior antiretroviral history.
An autopsy-based study examined long-term trends in HIV-related mortality among individuals living with the disease in New York City.
New and emerging strategies in the management of HIV
Top news of the day from across the health care landscape.
+ Load More